The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Alpine Immune Sciences, Inc(NASDAQ:ALPN) 
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline include ALPN-101, an inducible T cell costimula...
Website: http://www.alpineimmunesciences.com
Founded: 2007
Full Time Employees: 53
Sector: Healthcare
Industry: Biotechnology
Alpine Immune Sciences Days Payable Outstanding ttm (DPO)
Alpine Immune Sciences Days Receivable Outstanding ttm (DSO)
Alpine Immune Sciences Op Cashflow Per Share ttm
Alpine Immune Sciences Free Cashflow Per Share ttm
Alpine Immune Sciences Cash Per Share ttm
Alpine Immune Sciences P/S ratio ttm
Alpine Immune Sciences (GAAP) P/E ratio ttm
Alpine Immune Sciences P/B ratio ttm
No extra charts and metrics for this ticker.